Skip to main content
. 2021 Jul 5;33(2):128–135. doi: 10.4103/JOCO.JOCO_226_20

Table 3.

Distribution of antiglaucomatous medication number

Active principle number Patients, n (%) Total (%)
One active principle 74 (47.7) 74 (47.7)
Fixed combination 35 (22.6) 44 (28.4)
2 separate active principles 9 (5.8)
Fixed combination + one active principle 25 (16.1) 30 (19.4)
3 separate active principles 5 (3.3)
Fixed combination + 2 separate active principles 6 (3.9) 7 (4.5)
4 separate active principles 1 (0.6)
Total 155 155